Fibrogen Stock Widgets and Gadgets
FGEN Stock | USD 2.35 0.23 8.91% |
Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- FGEN FibroGen
- Latest Apogee Stock Rallies 95.6 percent in a Month Heres Why
- FGEN 2.35 -0.23
- Low 2.31
- High 2.59
- Volume 1.4 M
- Alpha 1.77
- Beta 5.29
- Return On Equity -10.16
- Return On Asset -0.36
- Profit Margin (1.92) %
- Operating Margin (3.81) %
- Current Valuation 171.3 M
- Shares Outstanding 98.77 M
- Shares Owned By Insiders 6.36 %
- Shares Owned By Institutions 71.44 %
- Number Of Shares Shorted 5.53 M
- Price To Earning 97.67 X
- Price To Book 53.83 X
- Price To Sales 1.60 X
- Revenue 147.75 M
- Gross Profit (159.21 M)
- EBITDA (259.28 M)
- Net Income (284.23 M)
- Cash And Equivalents 438.13 M
- Cash Per Share 4.67 X
- Total Debt 170.46 M
- Debt To Equity 0.89 %
- Current Ratio 2.17 X
- Book Value Per Share (2.07) X
- Cash Flow From Operations (315.02 M)
- Short Ratio 3.12 X
- Earnings Per Share (2.92) X
- Target Price 1.25
- Number Of Employees 486
- Beta 0.66
- Market Capitalization 236.06 M
- Total Asset 423.53 M
- Retained Earnings (1.84 B)
- Working Capital 113.89 M
- Current Asset 200.56 M
- Current Liabilities 67.18 M
- Z Score -6.61
- Net Asset 423.53 M
- Accumulation Distribution 146684.0
- Daily Balance Of Power (0.82)
- Rate Of Daily Change 0.91
- Day Median Price 2.45
- Day Typical Price 2.42
- Price Action Indicator (0.21)
- Period Momentum Indicator (0.23)
Market Snapshot Widget Example
DAX Index Germany | 18,492 0.08 | |
Taiwan Weighted Taiwan | 20,147 0.27 | |
PSI 20 Stock Portugal | 6,280 0.06 | |
CROBEX Croatia | 2,835 0.28 | |
Budapest SE Hungary | 65,385 0.86 | |
IDX 30 Jakarta Indonesia | 501.16 0.43 | |
ISEQ 20 Price Ireland | 1,637 0.3 | |
NYSE Comp USA | 18,313 0.31 | |
Tel Aviv 35 Israel | 2,009 0.52 | |
Coreshares Index Tracker South Afric | 1,052 0.57 | |
IPC MEXICO Mexico | 57,369 0.28 | |
KL Technology Malaysia | 64.31 0.42 | |
IBEX 35 Index Spain | 11,075 0.33 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,536 0.35 | |
SPASX Dividend Opportunities Australia | 1,686 1.06 | |
HNX 30 Vietnam | 535.69 0.53 | |
Bucharest BET-NG Romania | 1,210 0.34 | |
AMS Small Cap Netherlands | 1,223 0.45 | |
Oslo Exchange Mutual Norway | 1,280 0.47 | |
BEL Small Belgium | 9,273 0.52 | |
RTSI Index Russia | 1,126 0.19 | |
Basic Materials Brazil | 6,016 0.18 | |
Swiss Leader Price Switzerland | 1,924 0.25 | |
Athens General Comp Greece | 1,422 0.34 | |
Stock Exchange Of Thailand | 1,370 0.76 | |
PX Prague Stock Czech Repub | 1,513 1.55 | |
THE PHILIPPINE STOCK Philippines | 6,904 0.08 | |
WIG 30 Poland | 3,022 1.59 | |
BIST Electricity Turkey | 544.86 1.57 |
Investing Ideas
In addition to having FibroGen in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare FibroGen
Compare FibroGen To Peers
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in FibroGen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. To learn how to invest in FibroGen Stock, please use our How to Invest in FibroGen guide.Note that the FibroGen information on this page should be used as a complementary analysis to other FibroGen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for FibroGen Stock analysis
When running FibroGen's price analysis, check to measure FibroGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FibroGen is operating at the current time. Most of FibroGen's value examination focuses on studying past and present price action to predict the probability of FibroGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FibroGen's price. Additionally, you may evaluate how the addition of FibroGen to your portfolios can decrease your overall portfolio volatility.
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is FibroGen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of FibroGen. If investors know FibroGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about FibroGen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.536 | Earnings Share (2.92) | Revenue Per Share 1.518 | Quarterly Revenue Growth (0.21) | Return On Assets (0.36) |
The market value of FibroGen is measured differently than its book value, which is the value of FibroGen that is recorded on the company's balance sheet. Investors also form their own opinion of FibroGen's value that differs from its market value or its book value, called intrinsic value, which is FibroGen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because FibroGen's market value can be influenced by many factors that don't directly affect FibroGen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between FibroGen's value and its price as these two are different measures arrived at by different means. Investors typically determine if FibroGen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, FibroGen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.